BMRN

$0.00

(

0.00%

)
Quote details

stock

Biomarin Pharmaceutical Inc

NASDAQ | BMRN

56.38

USD

$0.00

(

0.00%

)

At Close (As of Sep 8, 2025)

$11.09B

Market Cap

17.04

P/E Ratio

3.39

EPS

$85.64

52 Week High

$52.93

52 Week Low

HEALTHCARE

Sector

BMRN Chart

Recent Chart
Price Action

BMRN Technicals

Tags:

BMRN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3B
Total Revenue $2.9B
Cost Of Revenue $580M
Costof Goods And Services Sold $580M
Operating Income $484M
Selling General And Administrative $879M
Research And Development $747M
Operating Expenses $1.8B
Investment Income Net -
Net Interest Income $62M
Interest Income $75M
Interest Expense $13M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $96M
Income Before Tax $542M
Income Tax Expense $115M
Interest And Debt Expense -
Net Income From Continuing Operations $427M
Comprehensive Income Net Of Tax -
Ebit $554M
Ebitda $651M
Net Income $427M

Revenue & Profitability

Earnings Performance

BMRN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $7B
Total Current Assets $3.2B
Cash And Cash Equivalents At Carrying Value $943M
Cash And Short Term Investments $943M
Inventory $1.2B
Current Net Receivables $661M
Total Non Current Assets $3.8B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $255M
Intangible Assets Excluding Goodwill $255M
Goodwill $196M
Investments -
Long Term Investments $521M
Short Term Investments $195M
Other Current Assets $202M
Other Non Current Assets -
Total Liabilities $1.3B
Total Current Liabilities $607M
Current Accounts Payable $235M
Deferred Revenue -
Current Debt -
Short Term Debt $7.6M
Total Non Current Liabilities $724M
Capital Lease Obligations $7.6M
Long Term Debt $595M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $603M
Other Current Liabilities $350M
Other Non Current Liabilities $129M
Total Shareholder Equity $5.7B
Treasury Stock -
Retained Earnings -$195M
Common Stock $191K
Common Stock Shares Outstanding $197M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $573M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $96M
Capital Expenditures $97M
Change In Receivables -
Change In Inventory -$64M
Profit Loss -
Cashflow From Investment $136M
Cashflow From Financing -$526M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $427M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3B
Total Revenue $2.9B
Cost Of Revenue $580M
Costof Goods And Services Sold $580M
Operating Income $484M
Selling General And Administrative $879M
Research And Development $747M
Operating Expenses $1.8B
Investment Income Net -
Net Interest Income $62M
Interest Income $75M
Interest Expense $13M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $96M
Income Before Tax $542M
Income Tax Expense $115M
Interest And Debt Expense -
Net Income From Continuing Operations $427M
Comprehensive Income Net Of Tax -
Ebit $554M
Ebitda $651M
Net Income $427M

BMRN News

BMRN Profile

Biomarin Pharmaceutical Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
GNPX
+47.39%
$0.22
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
AAL
-0.99%
$12.95
SNAP
-1.16%
$7.22
NIO
+3.61%
$6.16
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
MARA
+0.06%
$15.20
RAYA
-12.69%
$0.03
DNN
+1.70%
$2.39
KVUE
-0.80%
$18.47
TLRY
-5.88%
$1.12
SOFI
+1.40%
$25.96
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
WBD
+2.10%
$12.36
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
IXHL
-9.48%
$0.52
INTC
-0.04%
$24.48
HL
+12.08%
$10.11
NVVE
+9.46%
$0.24
PFE
-1.24%
$24.57
BAC
-0.58%
$49.48
PLTR
+1.95%
$156.10
LDI
+31.48%
$3.80
BTG
+2.87%
$4.29
YAAS
-21.46%
$0.08
MBOT
+22.95%
$4.50
AAPL
-0.75%
$237.88
ILLR
+22.34%
$0.52
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AIRE
+16.00%
$0.47
BMNR
+4.28%
$43.84
AMD
+0.22%
$151.47
RR
+17.78%
$2.98
CPNG
+9.19%
$31.56
BBD
-0.47%
$3.16
HIMS
+2.60%
$49.67
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
AVGO
+3.40%
$346.30
GRAB
+0.58%
$5.19
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
HBAN
+0.36%
$17.69
F
-0.59%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
WLGS
-5.57%
$0.04
RIG
+2.93%
$3.16
ADAP
+3.65%
$0.04
KDP
-4.24%
$27.43
CIFR
+2.65%
$7.72
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
INFY
+2.53%
$16.79
CMG
-4.39%
$39.25
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
AFMD
-34.94%
$0.18
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
VZ
-2.62%
$43.21
CRWV
+5.00%
$93.55
ETHD
+1.96%
$3.63
QBTS
+0.55%
$15.45
JOBY
+0.43%
$13.51
IREN
+0.15%
$26.19
ITUB
-0.56%
$7.06
DVLT
+1.69%
$0.31
GOOG
-0.42%
$234.16
LYFT
+6.30%
$17.71
AG
+3.33%
$9.45
JD
+4.45%
$32.85
TAIT
+64.40%
$3.51
SLB
-0.06%
$35.79
BTE
+0.68%
$2.19
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
GNPX
+47.39%
$0.22
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
AAL
-0.99%
$12.95
SNAP
-1.16%
$7.22
NIO
+3.61%
$6.16
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
MARA
+0.06%
$15.20
RAYA
-12.69%
$0.03
DNN
+1.70%
$2.39
KVUE
-0.80%
$18.47
TLRY
-5.88%
$1.12
SOFI
+1.40%
$25.96
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
WBD
+2.10%
$12.36
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
IXHL
-9.48%
$0.52
INTC
-0.04%
$24.48
HL
+12.08%
$10.11
NVVE
+9.46%
$0.24
PFE
-1.24%
$24.57
BAC
-0.58%
$49.48
PLTR
+1.95%
$156.10
LDI
+31.48%
$3.80
BTG
+2.87%
$4.29
YAAS
-21.46%
$0.08
MBOT
+22.95%
$4.50
AAPL
-0.75%
$237.88
ILLR
+22.34%
$0.52
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AIRE
+16.00%
$0.47
BMNR
+4.28%
$43.84
AMD
+0.22%
$151.47
RR
+17.78%
$2.98
CPNG
+9.19%
$31.56
BBD
-0.47%
$3.16
HIMS
+2.60%
$49.67
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
AVGO
+3.40%
$346.30
GRAB
+0.58%
$5.19
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
HBAN
+0.36%
$17.69
F
-0.59%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
WLGS
-5.57%
$0.04
RIG
+2.93%
$3.16
ADAP
+3.65%
$0.04
KDP
-4.24%
$27.43
CIFR
+2.65%
$7.72
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
INFY
+2.53%
$16.79
CMG
-4.39%
$39.25
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
AFMD
-34.94%
$0.18
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
VZ
-2.62%
$43.21
CRWV
+5.00%
$93.55
ETHD
+1.96%
$3.63
QBTS
+0.55%
$15.45
JOBY
+0.43%
$13.51
IREN
+0.15%
$26.19
ITUB
-0.56%
$7.06
DVLT
+1.69%
$0.31
GOOG
-0.42%
$234.16
LYFT
+6.30%
$17.71
AG
+3.33%
$9.45
JD
+4.45%
$32.85
TAIT
+64.40%
$3.51
SLB
-0.06%
$35.79
BTE
+0.68%
$2.19

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.